SCM
LUCD icon

Sterling Capital Management’s Lucid Diagnostics LUCD Stock Holding History

Sterling Capital Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.19K Sell
1,900
-1,096
-37% -$1.4K ﹤0.01% 2975
2025
Q4 		$3.27K Buy
2,996
+124
+4% +$139 ﹤0.01% 2993
2025
Q3 		$2.9K Buy
2,872
+1,734
+152% +$1.89K ﹤0.01% 2919
2025
Q2 		$1.31K Buy
+1,138
New +$1.47K ﹤0.01% 3017

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Sterling Capital Management's LUCD Position: Q1 2026 in Review

Sterling Capital Management reduced its Lucid Diagnostics (LUCD) stake by 37% in Q1 2026, selling an estimated $1.4K and leaving 1,900 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2975.

Sterling Capital Management first reported a position in LUCD in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.27K in Q4 2025. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Sterling Capital Management held 1,900 shares of Lucid Diagnostics worth $2.19K as of Q1 2026.
  • Sterling Capital Management sold 1,096 Lucid Diagnostics shares in Q1 2026, an estimated $1.4K.
  • Lucid Diagnostics made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2975 holding.
  • Sterling Capital Management first reported a position in Lucid Diagnostics in Q2 2025 and has held it in 4 quarters since.
  • Sterling Capital Management's Lucid Diagnostics position peaked at $3.27K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.